Eyebrow High-Cost Therapy Profile: February Detailed information about Marnetegragene autotemcel Intravenous (IV) High Cost Therapy Profile Gene Therapy/Immunology Marnetegragene autotemcel...

The SIU promotes safety to prevent fraud, waste and abuse schemes

publications High Cost Therapy Profile: December 2024 Remestemcel-L Intravenous (IV) Mesoblast Limited December 11, 2024 Autoimmune/immunology Proposed indications Treatment of...

Support members with rare diseases We help members navigate rare diseases with our holistic, customized approach to care. Breadcrumb Home Our solutions Condition management Rare diseases Learn more...

Cover AMCP Prime Therapeutics /amcp-nexus-2024-research-posters 10 research posters presented by Prime at AMCP Nexus 2024 covers topics like GLP-1 obesity research, health equity initiatives, and...

Cover image for 8 research posters presented by Prime at the 2024 AMCP Annual Meeting 2024 AMCP Annual Meeting Prime Therapeutics /2024-amcp-annual-meeting-research-posters 8 research posters...

If you think about the rise of specialty drugs as a Category 5 hurricane, and the growth of gene therapies as an undersea earthquake, you can see the rising tsunami of drug spend looking to sweep...

Prime Therapeutics offers first-of-its-kind digital utilization management solution that pairs biomarker testing with targeted therapy drug selection

2024 AMCP Nexus Posters As presented at the 2024 Academy of Managed Care Pharmacy (AMCP) Nexus event. Click on the poster image to view the full-size version. Save: Making medications more...

Constant communication across the supply chain limits disruption when a drug is unavailable

Prime works to simplify medication management and support patients with migraine, making migraine treatment less of a pain point

publications Trending Topics & Drug Approvals: May 2025 Your source for the latest drug information highlights June 4, 2025 Trending Topics Hot topics The United States (U.S.) Food and Drug...

Parikh, director of medical pharmacy strategy at Prime/MRx, shares the latest on interchangeable biosimilars

Prime Therapeutics/Magellan Rx Management's signature event featured the hottest topics in specialty drug management and more

oncology insights Oncology Insights: 2024 Rewind January 16, 2025 Last year, Oncology Insights brought you the most talked about topics in 2024. As we enter this new year, let us review these...

Lead author David Eckwright shares more about the study “Real-World Extended Dosing Assessment for Eye(s) new to Faricimab-svoa Therapy.”

See our history Our teams have poured energy, integrity and compassion into transforming pharmacy solutions, turning barriers into breakthroughs. Breadcrumb Home Who we are Our history Tab 1 2021 –...

Prime’s Special Investigations Unit is specially trained to protect patients and providers throughout the health care continuum

New report highlights value-based contract solution and analysis of top 10 drug classes impacting Medicaid pharmacy net trend

Hero headline Forward copy that anchors in the key themes of our campaign: we are an organization you can trust, with solutions built for every plan, and people who will work to do what is right...